This content is from: Home
Gaviscon maker to pay £10 million for antitrust law breach
The UK competition watchdog the Office for Fair Trading has fined Reckitt Benckiser £10.2 million ($16 million) after the company admitted abusing its dominant position when supplying heartburn medicines to the National Health Service
To access our in-house intelligence please request a trial here.
Read this article – and more – for a one-week period.
REQUEST ACCESSAre you already an Managing IP subscriber? Login here